BridgeMD
New treatment option for Neck Pain
Official title Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS)
ClinicalTrials.gov ID: NCT06214949
What this study is testing
- What it's testing
- This study aims to assess the efficacy of Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) therapy to reduce chronic neck for military health system beneficiaries.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Military health care beneficiary for enrollment.
- Over the age of 18 years.
- Presence of chronic neck pain for at least 3 months.
You likely can't join if
- History of seizure, bipolar disorder, or schizophrenia.
- Unstable heart or pulmonary disease.
- Brain tumor, active brain infection, history of cerebral vascular accident (CVA), or penetrating brain injury.
- Use of medications that potentially lower seizure threshold without concomitant administration of anticonvulsant drugs that may protect against...
- Antiviral medications and antipsychotic medications
- Recent withdrawal from sedatives
See the full eligibility criteria
- Military health care beneficiary for enrollment.
- Over the age of 18 years.
- Presence of chronic neck pain for at least 3 months.
- History of seizure, bipolar disorder, or schizophrenia.
- Unstable heart or pulmonary disease.
- Brain tumor, active brain infection, history of cerebral vascular accident (CVA), or penetrating brain injury.
- Use of medications that potentially lower seizure threshold without concomitant administration of anticonvulsant drugs that may protect against seizure occurrence.
- Antiviral medications and antipsychotic medications
- Recent withdrawal from sedatives
- Substance abuse of phencyclidine, amphetamines, ketamine, and gammahydroxybutyrate
- Not a suitable candidate for the study as determined by the PI.
- Pregnancy, breastfeeding, or plans to become pregnant during the course of the study.
- Presence of metallic hardware in close contact to the discharging coil (e.g. cochlear implants, internal pulse generator).
- Presence of implanted brain electrodes (cortical or deep-brain electrodes).
- Potential participants who score above a certain suicide relevant survey score on the Suicide Behaviors Questionnaire-Revised (SBQ-R), or are judged by expert clinicians to be a serious risk of harm to self, will be...
- Participants cannot have undergone a previous TMS treatment within the last 30 days before the start of study treatment.
- Participants must have reliable and consistent access to the internet to complete surveys when not present in the clinic.
- Participants must not have a clinical diagnosis of insomnia.
- Participants can not be actively partaking in a substance abuse program.
The study team makes the final eligibility decision.
Where it's taking place
- Bethesda, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bethesda, Maryland, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.